LMO2 and acute lymphoblastic leukemia: Aberrant expression of Lmo2 results in the development of T-cell related diseases; indeed Lmo2 is located at a recurrent site of T-cell acute lymphoblastic leukemia (T-ALL) specific translocation [2], [4], [5], [6], [7], [8].